Clinical trial
PET and Recovery Following Revascularization (PARR 2)
NCT00385242 · Ottawa Heart Institute Research Corporation, Other · Completed
Key facts
| NCT number | NCT00385242 |
|---|---|
| Title | PET and Recovery Following Revascularization (PARR 2) |
| Official title | PET and Recovery Following Revascularization: Outcome and Cost-effectiveness of FDG PET in Left Ventricular Dysfunction (PARR 2) |
| Lead sponsor | Ottawa Heart Institute Research Corporation, Other |
| Collaborators | Canadian Institutes of Health Research (CIHR) Heart and Stroke Foundation of Ontario |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease, Ventricular Dysfunction, Left |
| Intervention type | Other, Procedure |
| Interventions | Positron emission tomography: FDG viability imaging, PET imaging |
| Enrollment | 430 |
| Start date | Jun 1, 2000 |
| Primary completion | Jun 1, 2006 |
| Completion | Jun 1, 2011 |
| First posted | Oct 9, 2006 |
| Last update posted | Nov 21, 2019 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: